View in EDS HTML Full Text PDF Full Text

A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.

Saved in:
Bibliographic Details
Title: A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.
Authors: Cancian M; Department of Systems Medicine, University Hospital of Padua, Padua, Italy., Caballero T; Department of Allergy, Hospital Universitario La Paz, Hospital La Paz Health Research Institute (IdiPAZ), Center for Biomedical Network Research on Rare Diseases (CIBERER) (U754), Madrid, Spain., Boccon-Gibod I; Department of Internal Medicine, National Reference Center for Angioedema (CREAK), Grenoble Alpes University Hospital (CHUGA), Grenoble, France., Buttgereit T; Angioedema Center of Reference and Excellence (ACARE), Institute of Allergology, Charité-Universitätsmedizin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Immunology and Allergology, Berlin, Germany., Cohn D; Department of Vascular Medicine, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands., Eren E; Department of Immunology, University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, United Kingdom., Kiani-Alikhan S; Department of Immunology, Royal Free London National Health Service Foundation Trust, London, United Kingdom., Launay D; Department of Internal Medicine and Clinical Immunology, National Reference Centre for Angioedema (CREAK), Centre Hospitalier Universitaire de Lille (CHU) Lille, University of Lille, French National Institute for Health Research (INSERM), Institute for Translational Research in Inflammation U1286, Lille, France., Mandelin J; Department of Dermatology and Allergology, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland., Zanichelli A; Operative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato, Milan, Italy.; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy., Farkas H; Hungarian Angioedema Center of Reference and Excellence, Department of Internal, Medicine and Haematology, Semmelweis University, Budapest, Hungary.
Source: Frontiers in immunology [Front Immunol] 2026 Feb 12; Vol. 17, pp. 1773279. Date of Electronic Publication: 2026 Feb 12 (Print Publication: 2026).
Publication Type: Consensus Statement; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41766887
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cancian+M%22">Cancian M</searchLink>; Department of Systems Medicine, University Hospital of Padua, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Caballero+T%22">Caballero T</searchLink>; Department of Allergy, Hospital Universitario La Paz, Hospital La Paz Health Research Institute (IdiPAZ), Center for Biomedical Network Research on Rare Diseases (CIBERER) (U754), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Boccon-Gibod+I%22">Boccon-Gibod I</searchLink>; Department of Internal Medicine, National Reference Center for Angioedema (CREAK), Grenoble Alpes University Hospital (CHUGA), Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Buttgereit+T%22">Buttgereit T</searchLink>; Angioedema Center of Reference and Excellence (ACARE), Institute of Allergology, Charité-Universitätsmedizin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Immunology and Allergology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cohn+D%22">Cohn D</searchLink>; Department of Vascular Medicine, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Eren+E%22">Eren E</searchLink>; Department of Immunology, University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kiani-Alikhan+S%22">Kiani-Alikhan S</searchLink>; Department of Immunology, Royal Free London National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Launay+D%22">Launay D</searchLink>; Department of Internal Medicine and Clinical Immunology, National Reference Centre for Angioedema (CREAK), Centre Hospitalier Universitaire de Lille (CHU) Lille, University of Lille, French National Institute for Health Research (INSERM), Institute for Translational Research in Inflammation U1286, Lille, France.<br /><searchLink fieldCode="AU" term="%22Mandelin+J%22">Mandelin J</searchLink>; Department of Dermatology and Allergology, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Zanichelli+A%22">Zanichelli A</searchLink>; Operative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato, Milan, Italy.; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Farkas+H%22">Farkas H</searchLink>; Hungarian Angioedema Center of Reference and Excellence, Department of Internal, Medicine and Haematology, Semmelweis University, Budapest, Hungary.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Feb 12; Vol. 17, pp. 1773279. <i>Date of Electronic Publication: </i>2026 Feb 12 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Consensus Statement; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41766887
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1773279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1773279
    Titles:
      – TitleFull: A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cancian M
      – PersonEntity:
          Name:
            NameFull: Caballero T
      – PersonEntity:
          Name:
            NameFull: Boccon-Gibod I
      – PersonEntity:
          Name:
            NameFull: Buttgereit T
      – PersonEntity:
          Name:
            NameFull: Cohn D
      – PersonEntity:
          Name:
            NameFull: Eren E
      – PersonEntity:
          Name:
            NameFull: Kiani-Alikhan S
      – PersonEntity:
          Name:
            NameFull: Launay D
      – PersonEntity:
          Name:
            NameFull: Mandelin J
      – PersonEntity:
          Name:
            NameFull: Zanichelli A
      – PersonEntity:
          Name:
            NameFull: Farkas H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 02
              Text: 2026 Feb 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1